58MO Evaluation of three pexidartinib doses in a global phase IV clinical study of patients with tenosynovial giant cell tumor (TGCT) who chose to continue treatment
Saved in:
| Published in: | ESMO open Vol. 9; p. 102448 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier Ltd
01-03-2024
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| ArticleNumber | 102448 |
|---|---|
| Author | Garcia, I.C. Carrasco Desai, J. Gordon, M. Rubinacci, M. Gelderblom, H. Lin, C-C. Wagner, A.J. Pousa, A. Lopez Tecson, K. Tap, W.D. Grimison, P. Wooddell, M. Cesari, M. Van Tine, B.A. Stacchiotti, S. Trent, J.C. Papai, Z. Ryan, C.W. |
| Author_xml | – sequence: 1 givenname: S. surname: Stacchiotti fullname: Stacchiotti, S. organization: Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy – sequence: 2 givenname: A.J. surname: Wagner fullname: Wagner, A.J. organization: Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA – sequence: 3 givenname: I.C. Carrasco surname: Garcia fullname: Garcia, I.C. Carrasco organization: Department Oncologia Medica, Virgen del Rocio University Hospital, Seville, Spain – sequence: 4 givenname: M. surname: Cesari fullname: Cesari, M. organization: Medical Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy – sequence: 5 givenname: M. surname: Gordon fullname: Gordon, M. organization: Medical Oncology, HonorHealth Research Institute, Scottsdale, AZ, USA – sequence: 6 givenname: C-C. surname: Lin fullname: Lin, C-C. organization: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan – sequence: 7 givenname: Z. surname: Papai fullname: Papai, Z. organization: Medical Oncology, Semmelweis University, Budapest, Hungary – sequence: 8 givenname: C.W. surname: Ryan fullname: Ryan, C.W. organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA – sequence: 9 givenname: W.D. surname: Tap fullname: Tap, W.D. organization: Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA – sequence: 10 givenname: J.C. surname: Trent fullname: Trent, J.C. organization: University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL, USA – sequence: 11 givenname: H. surname: Gelderblom fullname: Gelderblom, H. organization: Medical Oncology Depatrment, Leiden University Medical Center, Leiden, Netherlands – sequence: 12 givenname: P. surname: Grimison fullname: Grimison, P. organization: Medical Oncology Depatrment, Chris O'Brien Lifehouse, Sydney, NSW, Australia – sequence: 13 givenname: A. Lopez surname: Pousa fullname: Pousa, A. Lopez organization: Medical Oncology, Hospital de la Santa Cruz i Sant Pau, Barcelona, Spain – sequence: 14 givenname: B.A. surname: Van Tine fullname: Van Tine, B.A. organization: Siteman Cancer Center, and Washington University School of Medicine in St. Louis, St. Louis, MO, USA – sequence: 15 givenname: M. surname: Rubinacci fullname: Rubinacci, M. organization: Clinical Operations, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA – sequence: 16 givenname: K. surname: Tecson fullname: Tecson, K. organization: Biostatistics Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA – sequence: 17 givenname: M. surname: Wooddell fullname: Wooddell, M. organization: Global Oncology Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA – sequence: 18 givenname: J. surname: Desai fullname: Desai, J. organization: Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia |
| BookMark | eNp9kM1u2zAQhIkgAZKmeYMe9pge7PJHoqRLgMJwUwMucnF6JShqFdGQSYGk7fqB8p6h4R566mkHg53ZxfeJXDvvkJAvjM4ZZfLbdo5x5_0055QX2eJFUV-RO07LZlZR3lz_o2_JQ4xbSimrimzKO_Je1r9eYHnQ414n6x34HtIQEGHCP7bTIVlnW-h8xAjWgYa30bd6hGnQEWH1G8yYN0x2Ytp3p3N-yk3oUoSjTQMkdD6enD_YvPNmtUtgcBwh7Xc-wOPmebH5CsfBgxnyEUhZeJev7rMOqNMuV30mN70eIz78nffk9cdys_g5W788rxbf1zPDClnPuKh5KUXFhdSiLWRL24aXvO5F2XSSGlm1rUbWN7xFamrWG1EZIxomNdair8Q9KS69JvgYA_ZqCnanw0kxqs601VZdaKszbXWhnWNPlxjm3w4Wg4omEzDY2YAmqc7b_xd8ACqxjjE |
| ContentType | Journal Article |
| Copyright | 2024 |
| Copyright_xml | – notice: 2024 |
| DBID | 6I. AAFTH AAYXX CITATION |
| DOI | 10.1016/j.esmoop.2024.102448 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2059-7029 |
| ExternalDocumentID | 10_1016_j_esmoop_2024_102448 S2059702924002163 |
| GroupedDBID | .1- .FO 0R~ 53G 5VS 6I. 9YT AAEDW AAFTH AAXUO ACGFS ACMMV ADBBV ADRAZ AFCTW AFRHN AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV EBS FDB GROUPED_DOAJ HYE KQ8 M48 M~E O9- OK1 RHI ROL RPM Z5R AALRI AAYXX ADVLN AFJKZ AITUG CITATION |
| ID | FETCH-LOGICAL-c1468-23825637236a3b46b0b92528f359d60c67bbae1f92be0c81fc37cc3916ae83f73 |
| ISSN | 2059-7029 |
| IngestDate | Thu Nov 21 22:57:23 EST 2024 Sat Mar 16 16:13:56 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1468-23825637236a3b46b0b92528f359d60c67bbae1f92be0c81fc37cc3916ae83f73 |
| OpenAccessLink | http://dx.doi.org/10.1016/j.esmoop.2024.102448 |
| ParticipantIDs | crossref_primary_10_1016_j_esmoop_2024_102448 elsevier_sciencedirect_doi_10_1016_j_esmoop_2024_102448 |
| PublicationCentury | 2000 |
| PublicationDate | March 2024 2024-03-00 |
| PublicationDateYYYYMMDD | 2024-03-01 |
| PublicationDate_xml | – month: 03 year: 2024 text: March 2024 |
| PublicationDecade | 2020 |
| PublicationTitle | ESMO open |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0001742056 |
| Score | 2.3006876 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | 102448 |
| Title | 58MO Evaluation of three pexidartinib doses in a global phase IV clinical study of patients with tenosynovial giant cell tumor (TGCT) who chose to continue treatment |
| URI | https://dx.doi.org/10.1016/j.esmoop.2024.102448 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3fi9NAEMeX3gnii_gTzx_HPPighIQ02WbTx6PWuxOqYKuILyG72b324JLSpP74g_w_ndn8qlpEBV9CWLppyHyymUy-M8PYU8FVKI1OXa507HJuIryljHAlDwNf69DEnHKHz-bi9Yf4xZRPB4O29WM_9l8tjWNoa8qc_QtrdwfFAdxHm-MWrY7bP7L7KJ69caZdDe9aA7DR2lnrL6vMFg1YSScrSqvEctK2JMh6ic8zB18G-1zJtt50U3u1SYSrqLz417z4RLH2C6Srcij671TbK9usI16cThYUbPi8LBxcXEvbnIMk8at8q3tl-w_fBOZ40tTIqwv4VKlSS1KTWLXB3OsD_xdNis6J96obPaWOSNYNPvcmHqlYNmmpiu4Diy7TOqN-5u2GOQLe67zq2Fubf9OLnXCJDNA5dIXfxEz0nrFmjR_vfVrUgYtLT5dXRUHFSwNOpSx4XfvzpzrcczowHZdUtwG6sQfsWoCrGy2uH0dv-8Ce4PhL29SwPZM2ZdPqCn_9s_0u0Y6bs7jFbjbvJ3BSg3WbDXR-h12fNQqMu-wb8QU9X1AYsHzBLl9g-YJVDinUfIHlC87fQ8sXWL5ofssXEF-wyxdYvoD4AssXPCO6ngOyBZYtqHCnYQs6tu6xdy-ni8mZ27T6cJXN_UPHEX3vUARhlIaSR9KX42AUxCYcjbPIV5GQMtVDMw6k9lU8NCoUSlHSeKrj0IjwPjvMi1w_YGCowJEeD9VQSrSUkDEPjNAqTo2fZaE5Ym57tZN1XdElaaWOl0ltnYSsk9TWOWKiNUnSeKW1t5kgRr-d-fCfZz5iN_p74DE7rDZb_YQdlNn22AaNji1y3wHyi7On |
| link.rule.ids | 315,782,786,866,27933,27934 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=58MO+Evaluation+of+three+pexidartinib+doses+in+a+global+phase+IV+clinical+study+of+patients+with+tenosynovial+giant+cell+tumor+%28TGCT%29+who+chose+to+continue+treatment&rft.jtitle=ESMO+open&rft.au=Stacchiotti%2C+S.&rft.au=Wagner%2C+A.J.&rft.au=Garcia%2C+I.C.+Carrasco&rft.au=Cesari%2C+M.&rft.date=2024-03-01&rft.pub=Elsevier+Ltd&rft.issn=2059-7029&rft.eissn=2059-7029&rft.volume=9&rft_id=info:doi/10.1016%2Fj.esmoop.2024.102448&rft.externalDocID=S2059702924002163 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-7029&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-7029&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-7029&client=summon |